Medtronic plc MDT Income Statement

Medtronic plc (MDT)

Income statement / TTM

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14
Net sales
31,062	30,891	30,666	30,557	30,555	30,378	29,947	29,953	29,725	29,639	29,934	29,710	29,361	29,012	28,725	28,833	28,570	25,954	23,262	20,261	0	0	0
Costs and expenses:
Cost of products sold
9,643	9,508	9,317	9,155	9,070	8,999	8,919	9,067	9,108	9,182	9,385	9,294	9,218	9,091	8,947	9,142	9,713	8,700	7,660	6,309	0	0	0
Research and development expense
2,357	2,345	2,332	2,330	2,328	2,326	2,292	2,256	2,217	2,188	2,186	2,193	2,215	2,231	2,222	2,224	2,177	2,004	1,833	1,640	0	0	0
Selling, general, and administrative expense
10,370	10,379	10,364	10,418	10,394	10,321	10,255	10,238	10,428	10,293	10,170	10,018	9,592	9,521	9,448	9,469	9,513	8,683	7,847	6,904	0	0	0
Amortization of intangible assets
1,754	1,754	1,758	1,764	1,775	1,800	1,815	1,823	1,871	1,907	1,947	1,980	1,967	1,954	1,937	1,931	1,916	1,521	1,127	733	0	0	0
Restructuring charges, net
173	186	183	198	119	100	84	30	164	178	217	303	293	291	317	290	366	347	274	237	0	0	0
Acquisition-related items
-	-	-	-	-	-	-	-	-	-	-	-	248	243	264	283	551	568	580	550	0	0	0
Certain litigation charges
276	231	110	166	166	164	164	61	61	218	218	300	300	82	108	26	26	26	0	-	0	0	-
Divestiture-related items
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Gain on sale of businesses
-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-
Other operating (income) expense, net
-68	-164	-85	-258	-453	-524	-621	-535	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Special charge
-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	-	-	-	0	0	-
Other expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-154	-117	-85	-107	-107	-122	-128	-118	0	0	0
Operating profit (loss)
6,421	6,324	6,517	6,268	6,250	6,144	6,494	6,640	6,396	6,107	5,598	5,383	5,274	5,482	5,397	5,361	4,159	4,079	3,809	3,766	0	0	0
Other non-operating income, net
369	344	288	373	423	213	268	181	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Investment loss
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	382	393	409	431	434	430	409	386	0	0	0
Interest expense
1,648	1,735	1,811	1,444	1,043	1,070	1,102	1,146	1,119	1,117	1,108	1,094	1,285	1,292	1,352	1,386	1,204	1,105	875	666	0	0	0
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-903	-899	-943	-955	-770	-675	-466	-280	0	0	0
Income (loss) before income taxes
5,142	4,933	4,994	5,197	5,630	5,287	5,660	5,675	5,385	5,325	4,809	4,602	4,301	4,513	4,384	4,336	3,389	3,404	3,343	3,486	0	0	0
Income tax provision
-207	232	544	547	697	3,017	2,497	2,580	2,591	319	705	578	338	275	737	798	955	1,088	719	811	0	0	0
Net income (loss)
5,349	4,701	4,450	4,650	4,933	2,270	3,163	3,095	2,794	5,006	4,104	4,024	3,955	3,655	0	-	0	0	-	-	-	-	-
Net income attributable to noncontrolling interests
34	32	30	19	14	9	0	-9	-13	-11	-11	-4	-5	-4	0	-	0	0	-	-	-	-	-
Net income (loss) attributable to Medtronic
5,315	4,669	4,420	4,631	4,919	2,261	3,163	3,104	2,807	5,017	4,115	4,028	3,968	4,242	3,647	3,538	2,434	2,316	2,624	2,675	0	0	0
Basic earnings per share (usd per share)
1.43	1.02	0.64	0.87	0.95	0.83	0.79	1.08	-1.03	1.49	0.75	0.84	0.60	0.81	0.67	0.78	0.78	0.37	0.58	-0.27	0.99	0.84	0.88
Diluted earnings per share (usd per share)
1.42	1.01	0.64	0.86	0.94	0.82	0.79	1.08	-1.03	1.48	0.74	0.84	0.59	0.80	0.66	0.78	0.77	0.36	0.57	-0.27	0.98	0.83	0.87
Basic weighted average shares outstanding (shares)
1,340	1,340	1,340	1,340	1,342	1,349	1,352	1,355	1,354	1,355	1,361	1,371	1,372	1,380	1,392	1,400	1,406	1,412	1,418	1,423	983	981	992
Diluted weighted average shares outstanding (shares)
1,351	1,351	1,351	1,351	1,352	1,360	1,365	1,377	1,354	1,365	1,375	1,382	1,383	1,392	1,407	1,416	1,422	1,428	1,436	1,442	995	993	1,005
Cash dividends declared per ordinary share (usd per share)
-	-	-	-	-	-	-	-	-	-	0.46	-	0.43	0.43	0.43	0.38	0.38	0.38	0.38	0.30	0.30	0.30	0.30